Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Stephen WANJALA"'
Autor:
Menard Chihana PhD, Nolwenn Conan MSc, Liesbet Ohler MSc, Helena Huerga PhD, Stephen Wanjala MSc, Charles Masiku MSc, Elisabeth Szumilin MS, MSPH, Tom Ellman BSc, MSc, MBChB, MRCP, Jean-Francois Etard PhD, David Maman PhD, Mary-Ann Davies MBChB, MMed, PhD
Publikováno v:
Journal of the International Association of Providers of AIDS Care, Vol 23 (2024)
Background The burden of advanced HIV disease remains a significant concern in sub-Saharan Africa. In 2015, the World Health Organization released recommendations to treat all people living with HIV (PLHIV) regardless of CD4 (“treat all”) and in
Externí odkaz:
https://doaj.org/article/c47e21830a744a289e292642d39cca9d
Autor:
Helena Huerga, Gabriella Ferlazzo, Stephen Wanjala, Mathieu Bastard, Paolo Bevilacqua, Elisa Ardizzoni, Joseph Sitienei, Maryline Bonnet
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Empirical treatment of tuberculosis (TB) may be necessary in patients with negative or no Xpert MTB/RIF results. In a context with access to Xpert, we assessed mortality in the 6 months after the initial TB consultation among HIV-
Externí odkaz:
https://doaj.org/article/73a6b3ff8a2b400fa377044f471f57eb
Autor:
Menard L. Chihana, Helena Huerga, Gilles Van Cutsem, Tom Ellman, Eric Goemaere, Stephen Wanjala, Charlie Masiku, Elisabeth Szumilin, Jean-Francois Etard, David Maman, Mary-Ann Davies
Publikováno v:
Global Health Action, Vol 12, Iss 1 (2019)
Background: Despite substantial progress in antiretroviral therapy (ART) scale up, some people living with HIV (PLHIV) continue to present with advanced HIV disease, contributing to ongoing HIV-related morbidity and mortality. Objective: We aimed to
Externí odkaz:
https://doaj.org/article/44a0ccfdcac04120bafaeac89923f0aa
Autor:
Valarie Sarah Opollo, Alliance Nikuze, Jihane Ben-Farhat, Emily Anyango, Felix Humwa, Boaz Oyaro, Stephen Wanjala, Willis Omwoyo, Maxwel Majiwa, Victor Akelo, Clement Zeh, David Maman
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0209778 (2018)
BackgroundAccess to point-of-care HIV testing shortens turn-around times, time to diagnosis and reduces loss to follow-up hence minimizing barriers to early linkage to care and treatment among HIV infected infants. Currently samples for early infant
Externí odkaz:
https://doaj.org/article/686ee73828254d15b3a0a5d20b4407e4
Autor:
Menard Laurent Chihana, Helena Huerga, Gilles Van Cutsem, Tom Ellman, Stephen Wanjala, Charles Masiku, Elisabeth Szumilin, Jean Francois Etard, Mary-Ann Davies, David Maman
Publikováno v:
PLoS ONE, Vol 13, Iss 11, p e0207656 (2018)
BACKGROUND:Latest WHO guidelines recommend starting HIV-positive individuals on antiretroviral therapy treatment (ART) regardless of CD4 count. We assessed additional impact of adopting new WHO guidelines. METHODS:We used data of individuals aged 15-
Externí odkaz:
https://doaj.org/article/9cad149da86b4ed78fd38333f4d5eeb5
Autor:
Helena Huerga, Gabriella Ferlazzo, Paolo Bevilacqua, Beatrice Kirubi, Elisa Ardizzoni, Stephen Wanjala, Joseph Sitienei, Maryline Bonnet
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0170976 (2017)
Determine-TB LAM assay is a urine point-of-care test useful for TB diagnosis in HIV-positive patients. We assessed the incremental diagnostic yield of adding LAM to algorithms based on clinical signs, sputum smear-microscopy, chest X-ray and Xpert MT
Externí odkaz:
https://doaj.org/article/3f7aea4aba3548eba5ce1d402af9f751
Autor:
Robin Nesbitt, Menard Chihana, Helena Huerga, Elisabeth Szumilin, Leonard Kingwara, Nolwenn Conan, Valarie Opollo, Catherine Ngugi, Leon Salumu, Stephen Wanjala, Christopher Mambula, Gordon Okomo, Mahmoud Badawi
Publikováno v:
Tropical Medicine & International Health. 26:1609-1615
BACKGROUND HIV-positive individuals who maintain an undetectable viral load cannot transmit the virus to others. In 2012, an HIV population-based survey was conducted in Ndhiwa sub-county (Kenya) to provide information on the HIV local epidemic. We c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ad685a8a3a1fd2fbdbc10c9f2864bc4
https://doi.org/10.1111/tmi.13688
https://doi.org/10.1111/tmi.13688
Autor:
Helena Huerga, Mathieu Bastard, Alex Vicent Lubega, Milcah Akinyi, Natalia Tamayo Antabak, Liesbet Ohler, Winnie Muyindike, Ivan Mugisha Taremwa, Rosanna Stewart, Claire Bossard, Nothando Nkosi, Zibusiso Ndlovu, Catherine Hewison, Turyahabwe Stavia, Gordon Okomo, Jeremiah Okari Ogoro, Jacqueline Ngozo, Mduduzi Mbatha, Couto Aleny, Stephen Wanjala, Mohammed Musoke, Daniel Atwine, Alexandra Ascorra, Elisa Ardizzoni, Martina Casenghi, Gabriella Ferlazzo, Lydia Nakiyingi, Ankur Gupta-Wright, Maryline Bonnet
Publikováno v:
The Lancet global health
The Lancet global health, 2023, 11 (1), pp.e126-e135. ⟨10.1016/S2214-109X(22)00463-6⟩
The Lancet global health, 2023, 11 (1), pp.e126-e135. ⟨10.1016/S2214-109X(22)00463-6⟩
International audience; Background: Development of rapid biomarker-based tests that can diagnose tuberculosis using non-sputum samples is a priority for tuberculosis control. We aimed to compare the diagnostic accuracy of the novel Fujifilm SILVAMP T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a6e9922da114d25f3b25aa23048bdbc
https://pubmed.ncbi.nlm.nih.gov/36521944
https://pubmed.ncbi.nlm.nih.gov/36521944
Autor:
Tom Ellman, Lakshmi Jain, Lubbe Wiesner, Valarie Opollo, Elisabeth Szumilin, Gilles van Cutsem, Gisele Mucinya, Elisabeth Poulet, Claire Bossard, David Maman, Stephen Wanjala, Birgit Schramm
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes (1999)
Supplemental Digital Content is Available in the Text.
Background: Patients hospitalized with advanced HIV have a high mortality risk. We assessed viremia and drug resistance among differentiated care services and explored whether expediting the
Background: Patients hospitalized with advanced HIV have a high mortality risk. We assessed viremia and drug resistance among differentiated care services and explored whether expediting the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd7799fae0a47a58222b11c49f1ef2d3
https://doi.org/10.1097/qai.0000000000002689
https://doi.org/10.1097/qai.0000000000002689
Autor:
S.S. Islam, Kwonjune J. Seung, Mir Zeeshan Ali Khan, J Kliesckova, Y M Tassew, Nara Melikyan, Carole D. Mitnick, Naira Khachatryan, D Damtew, Francis Varaine, Helena Huerga, Anita Mesic, P Lenggogeni, H Karakozian, N Lachenal, M Mofolo, Saman Ahmed, Stephen Wanjala, S. Cloez, Cathy Hewison, Leonid Lecca, Aamir J. Khan, Christophe Perrin, Uzma Khan, M Richard, Palwasha Khan, K Herboczek, Mathieu Bastard, Stalz Charles Vilbrun, Alex Telnov, S Maretbayeva, Tinatin Kotrikadze, Molly F. Franke, Michael Rich
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 24:1081-1086
In 2015, the initiative Expand New Drug Markets for TB (endTB) began, with the objective of reducing barriers to access to the new and repurposed TB drugs. Here we describe the major implementation challenges encountered in 17 endTB countries. We pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72f7b136d4c251286bc9fdd23e541d83
https://doi.org/10.5588/ijtld.20.0141
https://doi.org/10.5588/ijtld.20.0141